BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17207174)

  • 1. Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients.
    Schulz P; Bunselmeyer B; Bräutigam M; Luger TA
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):90-4. PubMed ID: 17207174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients.
    Oppel T; Pavicic T; Kamann S; Bräutigam M; Wollenberg A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1175-80. PubMed ID: 17894701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants.
    Kaufmann R; Fölster-Holst R; Höger P; Thaçi D; Löffler H; Staab D; Bräutigam M;
    J Allergy Clin Immunol; 2004 Nov; 114(5):1183-8. PubMed ID: 15536429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
    Zuberbier T; Bräutigam M
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
    Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
    J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
    Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
    J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis.
    Breuer K; Braeutigam M; Kapp A; Werfel T
    Dermatology; 2004; 209(4):314-20. PubMed ID: 15539895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
    Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
    Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
    McCaughey C; Machan M; Bennett R; Zone JJ; Hull CM
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1061-7. PubMed ID: 21175873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
    Fleischer AB; Abramovits W; Breneman D; Jaracz E;
    J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
    Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
    J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
    Sigurgeirsson B; Ho V; Ferrándiz C; Andriano K; Grinienko A; Jimenez P;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.